Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MICT: Streamlining Asthma Clinical Trials via Mobile Devices
NCT02061280Phase 4Completed
- Sponsor
- Nemours Children's Health
- Start
- Oct 2013
- Primary completion
- Feb 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fluticasone propionate and salmeterol in asthma, sponsored by Nemours Children's Health. Primary endpoint: Adolescent Research Participant Assessment at Screening. Started Oct 2013; status: completed.
02
Drugs
fluticasone propionatesalmeterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02061280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02061280.